New Drug Applications Cosmo Pharmaceuticals Announces Submission of Remimazolam NDA to FDA 6 years ago
New Drug Applications Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD 6 years ago